Kraig Biocraft Laboratories, Inc. (KBLB.OB) Achieves Higher Levels of Transient Expression of Targeted DNA
Kraig Biocraft Laboratories, Inc. was very pleased to announce this morning that scientists working in the company's sponsored research program at the University of Notre Dame have significantly increased the number and proportion of DNA insertions that yield transient expression of the company's targeted marker protein. "These results, which are occurring in the latest generation of genetic insertions performed in the laboratory, are very exciting, and we believe that it is further evidence that the research team is on the right track," commented CEO Kim K. Thompson. This increase is in both absolute numbers and in the percentage of insertions,…